Severe asthma paediatric - dupilumab or omalizumab - initial or recommencement authority application form (PB188)

Use this form to apply for initial PBS-subsidised treatment with dupilumab or omalizumab for patients 6 to under 12 years with uncontrolled severe asthma or uncontrolled severe allergic asthma.

You can also use this form to apply to recommence PBS-subsidised treatment with dupilumab or omalizumab in a new treatment cycle following a mandatory 12-month break.

Please note: You don’t need to complete this form if you use the Online PBS Authorities system.

Download and complete the severe asthma paediatric - dupilumab or omalizumab - initial or recommencement authority application form.

Page last updated: 1 September 2025.
QC 35876